Free Republic

http://www.express.co.uk/news/science/688379/Breakthrough-cancer-super-drug-can-also-be-used-to-beat-ebola-and-HIV By Sean Martin 16:59, Mon, Jul 11, 2016 | UPDATED: 17:06, Mon, Jul 11, 2016 Breakthrough cancer super-drug can also be used to beat ebola and HIV The breakthrough cancer therapy could be a “universal” therapy against flu and has the ability to destroy bacteria which has been failed by traditional medicines. Scientists behind the discovery say that the drug works by hurting the engine of viruses and cancers in cells while not affecting the rest of the body. The drug, known as AR-12, is now being brought to the UK by a pharmaceutical company for clinical trials against...

When scientists injected spores of a weakened form of the bacterium Clostridium novyi directly into the soft-tissue tumors of dogs and that of a single human subject, the results were not only abscesses, fever and pain at the site--all inflammatory responses that showed the immune system had been drawn to the area. In a matter of hours, the bacterial spores quickly found their way into these tumors' necrotic cores and began replicating madly, in several cases killing the malignant tissue. In three of 16 dogs treated with the C. novyi, tumors disappeared altogether and the animals were cured. In three...

The technique, which involves a simple injection, could aid the recovery of hundreds of thousands of heart failure patients - and could even consign heart transplants to history. Researchers hope to increase levels of SERCA2a, a protein in heart muscle cells that plays an important role in heart muscle contraction The technique, which involves a simple injection, could aid the recovery of hundreds of thousands of heart failure patients. Heart transplants could even be consigned to history thanks to a trial by Imperial College, London, which aims to show for the first time that gene therapy could repair failing organs....

An hour's drive to the southeast, at Cedars-Sinai Medical Center in Los Angeles, Dr. Eduardo Marban has recently launched an experiment to help patients like Karpman. Marban led one of the earlier stem cell trials, using cells taken by biopsy from the patient's own heart. The cells were multiplied in a laboratory for two to three weeks and then reinfused through a catheter. At the time, says Marban, it was thought that the stem cells themselves turned into new heart muscle and blood vessels. "In fact, the more we learned, the more we realized that that's not what these cells...